VBI Vaccines Inc/BC — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5a2081b8-a90b-48c5-9635-05ef5dd9d8bb/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $8.7M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014744 |
| FY 2022 | $1.1M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-007351 |
| FY 2021 | $631.0k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-006140 |
| FY 2020 | $1.1M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-005171 |
| FY 2019 | $2.2M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-003413 |
| FY 2018 | $3.4M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-002481 |
| FY 2017 | $865.0k | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-002481 |
| FY 2016 | $548.0k | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-002629 |
| FY 2015 | $955.0k | 2015-01-01 – 2015-12-31 | evidence 0001493152-17-002629 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
VBI Vaccines Inc/BC — all facts · Net Income · Operating Income